CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study

Thomas O Bergmeijer, Paul W A Janssen, Jurjan C Schipper, Khalid Qaderdan, Maycel Ishak, Rianne S Ruitenbeek, Folkert W Asselbergs, Arnoud W J van 't Hof, Willem J M Dewilde, Fabrizio Spanó, Jean-Paul R Herrman, Johannes C Kelder, Maarten J Postma, Anthonius de Boer, Vera H M Deneer, Jurriën M ten Berg

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science